Stephen Rudin, PhD.

Stephen Rudin, PhD, is developing a micro-angiographic fluoroscope to improve image-guided neurovascular diagnosis and interventions.

NIH Awards Rudin $2.5 Million to Advance Radiographic Imaging

Published February 18, 2013 This content is archived.

Story by Alexandra Edelblute

Stephen Rudin, PhD, director of radiology’s radiation physics division, has won a four-year, $2.5 million grant from the National Institutes of Health to continue developing state-of-the-art technology within a new class of imaging detectors.

Print

Rudin’s research has the potential to translate into manufactured medical systems providing new standards of care in neurovascular medicine.

Improving Image-Guided Intervention

Rudin and other collaborators are furthering the development of a high-resolution, region-of-interest X-ray imaging detector.

With qualities superior to standard X-ray image intensifiers and flat panel detectors, the micro-angiographic fluoroscope (MAF) will provide better images while minimizing patients’ radiation doses.

Rudin’s research, funded through the National Institute of Biomedical Imaging and Bioengineering, seeks to improve image-guided neurovascular diagnosis and refine neurovascular interventions.

Perfecting Technology, Continuing Testing

The MAF was constructed by Rudin and his collaborators during earlier phases of research.

Recently, they achieved promising results after using the MAF to guide human interventions.

Moving forward, their research will focus on enhancing the detector system technology. They plan to continue testing on patients as developments are implemented.

While the researchers are focused on neurovascular applications, they believe their developing medical imaging concepts may apply to all endovascular procedures, including cardiovascular diagnoses and interventions, peripheral vascular diagnoses and intervention, and pediatric procedures.

Research Collaborators from UB and Beyond

Rudin, a SUNY Distinguished Professor, is joined by several UB collaborators, including:

Michael Silver, PhD, vice president for research at Toshiba Medical Research Institute USA, is also working on the project.